Exploring the utility of organo-polyoxometalate hybrids to inhibit SOX transcription factors

Background: SOX transcription factors constitute an attractive target class for intervention with small molecules as they play a prominent role in the field of regenerative biomedicine and cancer biology. However, rationally engineering specific inhibitors that interfere with transcription factor DN...

Full description

Bibliographic Details
Main Authors: Kamesh Narasimhan, Kevin Micoine, Emmanuel Lacôte, Serge Thorimbert, Edwin Cheung, Bernold Hasenknopf, Ralf Jauch
Format: Article
Language:English
Published: SpringerOpen 2014-01-01
Series:Cell Regeneration
Online Access:http://www.sciencedirect.com/science/article/pii/S2045976917300275
id doaj-956251aed9a64272bba1c68e66bc1e57
record_format Article
spelling doaj-956251aed9a64272bba1c68e66bc1e572020-11-25T03:52:15ZengSpringerOpenCell Regeneration2045-97692014-01-013110.1186/2045-9769-3-10Exploring the utility of organo-polyoxometalate hybrids to inhibit SOX transcription factorsKamesh Narasimhan0Kevin Micoine1Emmanuel Lacôte2Serge Thorimbert3Edwin Cheung4Bernold Hasenknopf5Ralf Jauch6Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto M5S 3E1, CanadaUPMC Univ Paris 06, Institut Parisien de Chimie Moléculaire, Sorbonne Universités, UMR 8232, 4 Place Jussieu, Paris 75005, FranceUPMC Univ Paris 06, Institut Parisien de Chimie Moléculaire, Sorbonne Universités, UMR 8232, 4 Place Jussieu, Paris 75005, FranceUPMC Univ Paris 06, Institut Parisien de Chimie Moléculaire, Sorbonne Universités, UMR 8232, 4 Place Jussieu, Paris 75005, FranceGenome Institute of Singapore, 60 Biopolis Street, Buona Vista 138672, SingaporeUPMC Univ Paris 06, Institut Parisien de Chimie Moléculaire, Sorbonne Universités, UMR 8232, 4 Place Jussieu, Paris 75005, FranceGenome Institute of Singapore, 60 Biopolis Street, Buona Vista 138672, SingaporeBackground: SOX transcription factors constitute an attractive target class for intervention with small molecules as they play a prominent role in the field of regenerative biomedicine and cancer biology. However, rationally engineering specific inhibitors that interfere with transcription factor DNA interfaces continues to be a monumental challenge in the field of transcription factor chemical biology. Polyoxometalates (POMs) are inorganic compounds that were previously shown to target the high-mobility group (HMG) of SOX proteins at nanomolar concentrations. In continuation of this work, we carried out an assessment of the selectivity of a panel of newly synthesized organo-polyoxometalate hybrids in targeting different transcription factor families to enable the usage of polyoxometalates as specific SOX transcription factor drugs. Results: The residual DNA-binding activities of 15 different transcription factors were measured after treatment with a panel of diverse polyoxometalates. Polyoxometalates belonging to the Dawson structural class were found to be more potent inhibitors than the Keggin class. Further, organically modified Dawson polyoxometalates were found to be the most potent in inhibiting transcription factor DNA binding activity. The size of the polyoxometalates and its derivitization were found to be the key determinants of their potency. Conclusion: Polyoxometalates are highly potent, nanomolar range inhibitors of the DNA binding activity of the Sox-HMG family. However, binding assays involving a limited subset of structurally diverse polyoxometalates revealed a low selectivity profile against different transcription factor families. Further progress in achieving selectivity and deciphering structure-activity relationship of POMs require the identification of POM binding sites on transcription factors using elaborate approaches like X-ray crystallography and multidimensional NMR. In summary, our report reaffirms that transcription factors are challenging molecular architectures and that future polyoxometalate chemistry must consider further modification strategies, to address the substantial challenges involved in achieving target selectivity.http://www.sciencedirect.com/science/article/pii/S2045976917300275
collection DOAJ
language English
format Article
sources DOAJ
author Kamesh Narasimhan
Kevin Micoine
Emmanuel Lacôte
Serge Thorimbert
Edwin Cheung
Bernold Hasenknopf
Ralf Jauch
spellingShingle Kamesh Narasimhan
Kevin Micoine
Emmanuel Lacôte
Serge Thorimbert
Edwin Cheung
Bernold Hasenknopf
Ralf Jauch
Exploring the utility of organo-polyoxometalate hybrids to inhibit SOX transcription factors
Cell Regeneration
author_facet Kamesh Narasimhan
Kevin Micoine
Emmanuel Lacôte
Serge Thorimbert
Edwin Cheung
Bernold Hasenknopf
Ralf Jauch
author_sort Kamesh Narasimhan
title Exploring the utility of organo-polyoxometalate hybrids to inhibit SOX transcription factors
title_short Exploring the utility of organo-polyoxometalate hybrids to inhibit SOX transcription factors
title_full Exploring the utility of organo-polyoxometalate hybrids to inhibit SOX transcription factors
title_fullStr Exploring the utility of organo-polyoxometalate hybrids to inhibit SOX transcription factors
title_full_unstemmed Exploring the utility of organo-polyoxometalate hybrids to inhibit SOX transcription factors
title_sort exploring the utility of organo-polyoxometalate hybrids to inhibit sox transcription factors
publisher SpringerOpen
series Cell Regeneration
issn 2045-9769
publishDate 2014-01-01
description Background: SOX transcription factors constitute an attractive target class for intervention with small molecules as they play a prominent role in the field of regenerative biomedicine and cancer biology. However, rationally engineering specific inhibitors that interfere with transcription factor DNA interfaces continues to be a monumental challenge in the field of transcription factor chemical biology. Polyoxometalates (POMs) are inorganic compounds that were previously shown to target the high-mobility group (HMG) of SOX proteins at nanomolar concentrations. In continuation of this work, we carried out an assessment of the selectivity of a panel of newly synthesized organo-polyoxometalate hybrids in targeting different transcription factor families to enable the usage of polyoxometalates as specific SOX transcription factor drugs. Results: The residual DNA-binding activities of 15 different transcription factors were measured after treatment with a panel of diverse polyoxometalates. Polyoxometalates belonging to the Dawson structural class were found to be more potent inhibitors than the Keggin class. Further, organically modified Dawson polyoxometalates were found to be the most potent in inhibiting transcription factor DNA binding activity. The size of the polyoxometalates and its derivitization were found to be the key determinants of their potency. Conclusion: Polyoxometalates are highly potent, nanomolar range inhibitors of the DNA binding activity of the Sox-HMG family. However, binding assays involving a limited subset of structurally diverse polyoxometalates revealed a low selectivity profile against different transcription factor families. Further progress in achieving selectivity and deciphering structure-activity relationship of POMs require the identification of POM binding sites on transcription factors using elaborate approaches like X-ray crystallography and multidimensional NMR. In summary, our report reaffirms that transcription factors are challenging molecular architectures and that future polyoxometalate chemistry must consider further modification strategies, to address the substantial challenges involved in achieving target selectivity.
url http://www.sciencedirect.com/science/article/pii/S2045976917300275
work_keys_str_mv AT kameshnarasimhan exploringtheutilityoforganopolyoxometalatehybridstoinhibitsoxtranscriptionfactors
AT kevinmicoine exploringtheutilityoforganopolyoxometalatehybridstoinhibitsoxtranscriptionfactors
AT emmanuellacote exploringtheutilityoforganopolyoxometalatehybridstoinhibitsoxtranscriptionfactors
AT sergethorimbert exploringtheutilityoforganopolyoxometalatehybridstoinhibitsoxtranscriptionfactors
AT edwincheung exploringtheutilityoforganopolyoxometalatehybridstoinhibitsoxtranscriptionfactors
AT bernoldhasenknopf exploringtheutilityoforganopolyoxometalatehybridstoinhibitsoxtranscriptionfactors
AT ralfjauch exploringtheutilityoforganopolyoxometalatehybridstoinhibitsoxtranscriptionfactors
_version_ 1724483376487858176